Qi Biodesign

Developer of genome editing technologies for precision biological trait improvement

placeBeijing, Beijing, China calendar_todayFounded 2021 language qi-biodesign.com

Investor mix

10 investors on record; lead investors include Beijing Medical and Health Care Industry Investment Fund.

Investor typeCountShare
Venture capital660%
Private equity110%
Accelerator & incubator110%
Other / undisclosed220%
Coming soon